TrialInternational journal of hematology2025

Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.

Sung-Soo Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.